Exane Derivatives’s Microsoft MSFT Stock Holding History
Bought
Maintained
Sold
Other funds holding MSFT
Exane Derivatives's MSFT Position: Q2 2022 in Review
Exane Derivatives reduced its Microsoft (MSFT) stake by 14% in Q2 2022, selling an estimated $1.08M and leaving 24,041 shares worth $6.17M. The position accounts for 3.55% of the portfolio, ranked #2.
Exane Derivatives first reported a position in MSFT in Q4 2014 and has held it in 23 quarters since. The position peaked at $11M in Q2 2021. 4,507 funds tracked by Wall St. Rank hold MSFT as of Q2 2022.
- Exane Derivatives held 24,041 shares of Microsoft worth $6.17M as of Q2 2022.
- Exane Derivatives sold 3,983 Microsoft shares in Q2 2022, an estimated $1.08M.
- Microsoft made up 3.55% of Exane Derivatives's portfolio in Q2 2022, its #2 holding.
- Exane Derivatives first reported a position in Microsoft in Q4 2014 and has held it in 23 quarters since.
- Exane Derivatives's Microsoft position peaked at $11M in Q2 2021.
- 4,507 funds tracked by Wall St. Rank held Microsoft as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.